One-in-five Brits would expect to be sacked if they admitted to an alcohol or drug addiction

The UK's Attitudes to Addiction 2019 report

April 2019

One-in-five Brits would expect to be sacked if they admitted to an alcohol or drug addiction

A new report, released by addiction help and support service Port of Call, reveals that one-in-five (22%) people in the UK believe their employer would terminate their contract if they admitted to a drug or alcohol problem.

In the “Attitudes to Addiction report”, which was created to open up a public conversation about addiction issues and how others can support those affected; 19% of men said they thought they would be handed their P45 if they revealed they had an addiction to drugs or alcohol, compared to 26% of women.

It appears that this perception is also putting people off seeking help – 36% of those surveyed said they would not get professional help for fear it would hinder future job prospects.

Recent data* has shown that 1.3% of the adult population are alcohol dependent, if this is accurate it would mean a significant amount of people would be dismissed from their current roles.

So, what are the rules around this issue? Interestingly, businesses reserve the right to set their own policies and guidelines. However, almost a quarter (24%) of those surveyed said they didn’t know what their employer's rules were or how they would react.

The survey also revealed:

– 16-24 year-olds were the least optimistic when it came to suggesting what their employer would do if they admitted to an addiction – 31% would expect the boot

– 55+ were most likely to keep their addiction support a secret (14%)

– Almost half (49%) of people aged 55+ were the least worried about an addiction impacting future job prospects

– 24% of 16-24 year-olds thought their employers would put them on a final warning if they admitted to suffering from an addiction

Port of Call founder Martin Preston commented on the report findings:

“Most people who call us are in full-time employment and don’t want their employer to know they have an addiction problem, often for fear of losing their job.  Addiction is a shame-based illness and people can have a fear of being ‘found out’.

“We also take calls from employers who are trying to help a colleague, and often, even those with large HR and people teams, are unclear about what the firm’s stance really is.

“Most organisations have a zero- tolerance policy around alcohol and drug use, which they require for health and safety, yet rarely have awareness of, or access to, specialist addiction treatment services.

“Some firms, thankfully, are more progressive and we’re retained by a number of larger employers who genuinely want to help their people. If you’re employing more than ten people, addiction is an issue that you’re almost certain to encounter.”

Port of Call’s report “Attitudes to Addiction in 2019” can be accessed in full by clicking here –

Media contact:
Sacha Mooney
Senior PR Consultant
Zazzle Media
Phone: 01778 382713

Notes to Editors

– *Data cited from Public Health England’s ‘alcohol dependence prevalence’ report
– Supporting imagery and data visualisations are available
– Further expert comment and quotes available upon request

Company Background

– Port of Call is a website and helpline for anyone affected by addiction, as well as independent advisors on treatment services within the UK

– The Port of Call team refers people to the treatment services that it knows work, using vast knowledge of treatment professionals, support groups, counsellors, detox clinics and rehab centres and tailoring recommendations to individual circumstances and needs.

Sacha Mooney
Zazzle Media
+44 1778382713
email us here

Source: EIN Presswire

New ACH Payment Processing Rule for Web Transactions

Consider ACH Payment Processing

Consider ACH Payment Processing

ACH Processing

ACH Processing

ACH Payments

ACH Payments

Gulf Management Systems

ACH Payment Processing

Gulf Management Systems Prepares for New NACHA Rules via ACH Payment Solution and Unique ACH Payment API


Gulf Management Systems offers payment processing for New NACHA Rules via ACH Payment Solution and Unique API
A Florida-based leader in electronic payment processing sector ready for January 1, 2020 change with approaches to help keep businesses, software or applications compliant with new security standards.

Clearwater, FL – April 3, 2019 – Gulf Management Systems, a Clearwater, Florida-based leader in the electronic payment processing sector, announced it is preparing for new NACHA (National Automated Clearing House Association) rules – set to take effect on January 1, 2020 – by way of its respected ACH Recurring Payment Solution and unique API. Gulf Management representatives state that the company’s GMS Payments ACH Solution and API can help keep businesses, software or applications compliant with the new security standards, being that this is Gulf Management’s specialty.

NACHA, an organization that establishes the standards and rules followed by financial institutions for transferring payments, is implementing new rules for ACH WEB debit entries for the purpose of hindering fraudulent transactions, a change that will affect merchants accepting ACH payments via their website and/or software in which the consumer initiates the transaction.

This means, according to Gulf Management Systems representatives, that on a business’ website or software’s point of purchase initiated by the consumer, there needs to be a fraudulent transaction deletion system in place behind the scenes to filter ACH WEB transactions.

“These small changes are meant to protect businesses from fraud, but at the same time to protect consumers,” explains John Toston, Businesses Development Manager at Gulf Management Systems. “In addition to collecting this sensitive data, it is also imperative to utilize key tools to protect a business and consumers such as tokenization, signed authorization forms, electronic storage of authorization forms with tokens attached and more.

“Gulf’s GMS Payments ACH Solution and API help keep businesses, software and even applications compliant with the new upcoming security standards – primarily due to the fact that it’s our specialty.”

Gulf Management utilizes three steps to ensure payment security, encompassing authentication, verification, and authorization; the authentication stage confirms proper authentication of users’ or individuals’ payer, while the verification stage ensures complete verification of routing and account numbers upon the point of entry. The authorization stage is comprised of a process that validates account funds from the individual payer, completed at the point of transaction.

As a robust platform utilizing its API for ACH payments, Gulf Management’s Payment Gateway offers a myriad of options for clients to best serve their customers and simplify ACH payment processing. What’s more, Gulf’s API enables users to efficiently process ACH and Check 21 (Remote Deposit Capture) payments in real time, which can be used by an organization for its software and/or application to simplify billing.

“Our payment consultants work to create a unique customized solution that helps clients mitigate risks and navigate the rules with technology, so they can focus on building their business and making actions like recurring billing easier,” adds John Toston. “Indeed, Gulf Management Systems is not just a gateway or a processor – we seek to become part of every client’s business operations.

“To say that we’re very ‘hands-on’ when it comes to our ACH Solution is something of an understatement.”

Gulf Management Systems is located at 2753 SR 580 Suite 212 in Clearwater and can be reached by calling Sales at (855) 847-7764 or Customer Service at (800) 947-3156. For more information visit or email

John Toston
GMS Payments ACH
+1 8009473156
email us here

Source: EIN Presswire

Researchers Find Eight New Unique Gene Mutations in Patients with Hereditable Heart Muscle Disease

Anderson Graphic

Intermountain Healthcare Heart Institute researchers have identified eight new gene mutations that may cause or contribute to idiopathic dilated cardiomyopathy.

If it’s passed on in families, we’ll be able to identify those who might be at risk for developing heart disease and work to prevent it, diagnose it, and begin treatment earlier.”

— Dr. Jeffrey Anderson, Intermountain Healthcare Heart Institute

SALT LAKE CITY , UT, USA , April 17, 2019 / — In a new study from the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have identified eight new gene mutations that may cause or contribute to idiopathic dilated cardiomyopathy, a form of heart disease not caused by known external influences, such as high blood pressure, obesity, smoking, or diseased coronary arteries.

For at least 40 percent of these patients, the disease has an underlying genetic cause that leads to the muscle in the major pumping chamber of the heart (left ventricle) being too weak and thin to function properly, causing heart failure.

“Although many mutations contributing to non-ischemic dilated cardiomyopathy have been identified, there remains a large gap in our knowledge of its heritability. The more we can learn about what’s causing the condition, the better we can identify and treat it,” said Jeffrey L. Anderson, MD, principal investigator of the study, and a researcher at the Intermountain Healthcare Heart Institute. “If it’s passed on in families, we’ll be able to identify those who might be at risk for developing heart disease and work to prevent it, diagnose it, and begin treatment earlier.”

Findings from the study were presented at the American College of Cardiology’s Annual Scientific Session in New Orleans last month.

A quarter to one-third of idiopathic dilated cardiomyopathy patients will need a mechanical support device, a heart transplant, or will die within five years, Dr. Anderson noted, so this is a very serious condition.

In the study, researchers looked at genetic samples of 231 patients with idiopathic dilated cardiomyopathy, evaluated in an Intermountain Medical Center Specialty Clinic who volunteered to enter blood samples into the Intermountain Healthcare INSPIRE Registry and DNA Bank, which is the system’s collection of biological samples, clinical information, and laboratory data from consenting patients who are diagnosed with any of a number of healthcare-related conditions.

In collaboration with Intermountain’s Precision Genomics laboratory, researchers sequenced patients’ DNA, focusing on the TITIN (TNN) gene, which codes the body’s largest protein.

“That protein acts as a spring in your heart muscle,” said Dr. Anderson. “It enhances the passive elasticity of the muscle and also limits how much you can stretch it.”

Previous research has already found variants of TTN in patients with idiopathic dilated cardiomyopathy, but the story has been incomplete.

Now, in this new study, Intermountain researchers identified 24 patients with TTN variants, and eight of those variants hadn’t been seen or documented before. They also confirmed the presence of seven variants that had been discovered and reported previously. The new variants all are of the “truncating” variety, that is, they lead to a shortening of the protein and in doing so are predicted to cause the protein to malfunction in its role of maintaining the integrity of heart muscle function.

These new variants, Dr. Anderson said, still will require functional testing and clinical validation, but they likely will lead to further expansion of the known spectrum of genes that predispose to idiopathic dilated cardiomyopathy.

The addition of these variants to the current list of known pathological heart muscle protein mutations will help to close the still large gap in our knowledge of the heritability of heart muscle disease and in doing so can lead to earlier diagnosis and more effective prevention and treatment.

The study was funded by the Intermountain Foundation and an in-kind grant from Intermountain Precision Genomics.

Jess C. Gomez
Intermountain Healthcare
+1 801-718-8495
email us here

Source: EIN Presswire

NACCHO Highlights Need for Greater Support for Local Health Departments to Combat Rise in STDs

April is Sexually Transmitted Disease (STD) Awareness Month

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, April 17, 2019 / — STD Awareness Month is an opportunity to raise awareness about Sexually Transmitted Diseases (STDs), also referred to as Sexually Transmitted Infections (STIs), with local health departments and with local and national policymakers, stakeholders, and the public. The National Association of County and City Health Officials (NACCHO), the voice of the nation’s nearly 3,000 local health departments is working diligently to support their members’ work to address rising STD rates across the country and to implement innovative projects, such as its Express STI Visits Initiative, to provide new ways to link individuals to testing and treatment.

“Local health departments work hard every day to reduce STD rates and improve health outcomes in their communities by testing for, treating, and ultimately, preventing STDs. This includes strong prevention and treatment messaging, as well as the essential work of disease intervention specialists (DIS) who are on the frontlines of efforts to disrupt the spread of STDs and prevent outbreaks,” said NACCHO Chief Executive Officer Lori Tremmel Freeman. “But as NACCHO’s research shows, they need more support—stagnant or decreasing resources are not enough, and local health departments and their partners need more resources to address these rapidly rising STD rates.”

While STD rates are quickly increasing, federal, state, and local resources have stayed the same or decreased, leaving public health systems strained, including local health departments. In 2017, NACCHO queried its HIV, STI, and Viral Hepatitis Sentinel Network and found that nearly one-third of local health departments reported anticipating budget cuts in the next fiscal year and the majority experiencing stagnant funding for STD programs at best.
As the latest Centers for Disease Control and Prevention (CDC) STD Surveillance Report shows, STD rates increased for the fourth consecutive year in 2017, and there has been a steep, sustained increases in the incidence of all three reportable STDs.

Gonorrhea diagnoses increased by almost 70% percent overall and nearly doubled among men. Increases in diagnoses among women — and the speed with which they are increasing — are also concerning, with cases going up for the third year in a row.

Primary and secondary syphilis diagnoses increased 76%. Congenital syphilis (transmitted from the pregnant person to the fetus) cases rose sharply with 918 cases in 2017, a number that has more than doubled since 2013. This included 64 reported stillbirths as a result of congenital syphilis (up from 41 in 2016).

Chlamydia remained the most common condition reported to CDC. More than 1.7 million cases were diagnosed in 2017, with 45% of cases among 15- to 24-year-old females. The preliminary data for 2018 sadly shows these trends continuing and a new CDC analysis suggests that gay and bisexual men are at higher risk for extragenital STDs (e.g. chlamydia or gonorrhea in the throat or rectum), which increases treatment difficulty, drug resistance, and the risk of HIV infection. While these STDs are treatable, if untreated, they can cause serious health consequences such as pelvic inflammatory disease, infertility, and stillbirth.

Throughout STD Awareness Month, NACCHO is highlighting each of CDC’s four STD Awareness campaigns: Syphilis Strikes Back, GYT: Get Yourself Tested, Treat Me Right, and Talk. Test. Treat. New blog posts are available each Thursday of April and will feature work that local health departments and NACCHO are doing around the country to address STDs.

For more information, read about our STD work and check out our STD policy statement.

# # #

The National Association of County and City Health Officials (NACCHO) represents the nation’s nearly 3,000 local health departments. These city, county, metropolitan, district, and tribal departments work every day to protect and promote health and well-being for all people in their communities. For more information about NACCHO, please visit

Theresa Spinner
National Association of County and City Health Officials
+1 202-783-5551
email us here

Source: EIN Presswire

7 Tips On Filing A Defense Base Act Claim That You Need To Know






Doolittle & Tucker should be your go-to Defense Base Act attorneys. Call for a free case review with one of our

JACKSONVILLE, FLORIDA, UNITED STATES, April 17, 2019 / — You might recall the old joke, where a tourist in New York City stops a pedestrian on the street and asks, “How do I get to Carnegie Hall?” The pedestrian ruefully replies, “Practice, practice, practice.”

The joke is still a good one after all these years, and it brings to mind a similar sentiment with regard to the Defense Base Act. Namely, how do you make a claim under the Defense Base Act? Process, process, process.

Overseas Contractors for the U.S. Military – The Defense Base Act Is Your Workers’ Compensation Plan

Private contractors and other non-military workers employed overseas by the United States government should be aware of the Defense Base Act, which is an extension of the Longshore and Harbor Workers’ Compensation Act. Non-military personnel who do contract work for the military (most often in overseas military bases) have their workers’ compensation benefits administered by the Defense Base Act.

Therefore, if you are a civilian working for the U.S. military overseas and have been injured or a loved one has been killed, in a work-related incident, you need to turn to the Defense Base Act for compensation. To get that compensation you need to know a little about the claims process.

This article will give you 7 important tips to keep in mind whenever filing a Defense Base Act claim. However, it is highly recommended that you get the help of an experienced Defense Base Act lawyer to assist you. The “process, process, process” of a Defense Base Act claim could be tricky, and there are many potential pitfalls.

At Doolittle & Tucker, we are dedicated to helping people understand and avoid the pitfalls that come with any Defense Base Act claim. Our experienced Defense Base Act attorneys will make sure that you receive the workers’ compensation benefits to which you are entitled after a workplace accident.

Our attorneys are truly the best in Florida when it comes to Defense Base Act representation. We can do the work while you focus on the most important thing – healing. To learn more about our expertise on filing Defense Base Act claims after reading this article, call us at 904.396.1734. We will worry about your Defense Base Act claim, so you don’t have to.

Process, Process, Process

Before getting to the helpful tips, there are some basics you need to know about filing a Defense Base Act Claim. First, after an injury, or after a loved one is killed in a workplace incident, you need to inform the relevant supervisor of the accident as soon as possible.

Second, the injured person must provide notice to the employer, in writing, within 30 days of the accident. That written report will trigger the employer to provide medical treatment.

Finally, the injured person, or the family of a person killed in an incident, must file a so-called LS-203 form. This form is the Department of Labor’s claim form for compensation. On that form, you are able to give the details of your injury. The form should be filed with the Department of Labor’s Office of Workers’ Compensation Programs, and it should be filed within one year of the accident.

7 Tips For Filing a Defense Base Act Claim

In the “zone of danger,” you can still receive Defense Base Act compensation even if you were not actually working at the time you were injured. Unlike other workers’ compensation plans, the Defense Base Act does not necessarily require that a person is working at the time of the injury in order to receive benefits. The Act acknowledges that civilians on military bases, particularly in war zones like Iraq and Afghanistan, are in constant danger. Accordingly, you are eligible for workers’ compensation benefits even if you were injured during off-duty hours.

Inform your supervisor immediately, and get it in writing. Immediately after an injury, you should notify your supervisor. Yet, also be sure to send an email to your supervisor. That is helpful because, later on, you will likely need proof as to whether, and when, you notified your employer.

Keep track of all of your income, including bonuses. The compensation you receive through the Defense Base Act is calculated based upon your pre-injury wages. If you fail to report all of the income you earned on the job, then you are short-changing yourself of the compensation you deserve. Accordingly, keep track of all income, from any source, like bonuses.

Go to the doctor you choose, not the insurance company’s doctor. Upon filing a claim, the insurance company will likely recommend a physician. While that is helpful on the insurance company’s part, the Defense Base Act allows you to use your own physician. So, go to the best doctor you can find close to where you live.

Be diligent in gathering evidence to support your claim. The better you can support what happened in the incident, and the extent of your injuries, the better your compensation will be. With that in mind, do not forget to make a list of witnesses to the accident, with their contact information. Be sure to keep a diary of all the medical treatment you receive overseas. Also, try to get all medical records (including x-rays, MRI images, etc.) from all overseas medical providers.

Be honest about your injury. Do not take the risk that your claim will be denied by exaggerating your injury to your doctor or to the insurance company. Having a pre-existing condition prior to the injury does not mean that you will not get compensation. Under the Defense Base Act, insurance will still cover injuries that worsen a previous injury.
Finally, get a lawyer. The best thing you can do to file an effective Defense Base Act claim is to contact a seasoned Defense Base Act attorney.

Doolittle & Tucker should be your go-to Defense Base Act attorneys. In Florida, we are the Defense Base Act experts, and our representation is no cost to you unless we obtain compensation for you. So, call for a free case review with one of our attorneys who specialize in Defense Base Act cases. You can contact us today by calling 904.396.1734.

We have certainly become Defense Base Act specialists because we “practice, practice, practice” every day. Accordingly, we will be in your corner to cut through the challenging Defense Base Act “process, process, process.”

Mr. Zachary G. Tucker
Doolittle & Tucker, P.A.
email us here
Visit us on social media:

Why Should I Hire You For My Defense Base Act (DBA) Claim?

Source: EIN Presswire

Tech Mahindra and i2Chain Collaborate to Leverage Next Gen Technologies to Secure Confidential Customer Information

i2Chain Logo

i2Chain offers cybersecurity application leveraging blockchain technologies to secure information and data assets using a transactional model

SAN FRANCISCO, CA, UNITED STATES, DELHI, INDIA, April 17, 2019 / — Tech Mahindra Ltd., a leading provider of digital transformation, consulting and business reengineering services and solutions, announced a strategic collaboration with i2Chain Inc., a San Francisco-based startup, leveraging next gen technologies to secure customer information and data assets.

Through this partnership, Tech Mahindra and i2Chain will offer a blockchain-based cybersecurity application to customers that is easy to use and provides information owners with an unprecedented level of control as to how, when and where other users can access their information, with the potential to substantially reduce the frequency and costs of security incidents. It enables enterprises and users to secure, share and transact with integrity and confidence, and is fully GDPR (General Data Protection Regulation) compliant. The application also makes “chained” information and identity tamperproof, and records all actions taken against a file in an immutable blockchain, fully accessible to support audits and forensics.

Vivek Agarwal, Head of Corporate Development and Portfolio Companies, Tech Mahindra, said, “The size and volume of data enabled with the advent of 5G networks presents a challenge for enterprises to provide cost effective data security at the speed of business. I am excited to see that i2Chain can be leveraged as a strategic tool to secure high speed and high-volume information transactions especially in highly regulated industries including Finance, Media & Telecom, and Healthcare.”

Tech Mahindra will also provide consulting and other professional services, for the planning, deployment and ongoing support of the application to the users.

Rajesh Dhuddu, Global Practice Leader – Blockchain, Tech Mahindra, said, “This collaboration will enable Tech Mahindra to offer its customers across industries, an innovative and intuitive application to secure enterprise information and data assets through its entire life cycle. As part of the TechMNxt charter, we are actively building a partner ecosystem and leveraging next gen technologies to empower our customers to address their underserviced and unaddressed needs. Our strategic partnership with i2Chain is an important step in this direction.”

Ajay Jotwani, Cofounder and CEO, i2Chain, said, “We are delighted to partner with Tech Mahindra, a Forbes Top 100 Digital Company, with a sterling reputation for service, innovation and technology leadership. We are very excited about the solution we can offer to our mutual clients to help them secure information end-to-end while taking a very positive step into blockchain-based solutions for their businesses.”

As part of the TechMNxt charter, Tech Mahindra is betting big on next gen technologies like Blockchain, Cybersecurity, Artificial Intelligence, Machine Learning, 5G, Internet of Things (IoT), Robotics, and Analytics. Tech Mahindra is also collaborating and creating a disruptive and innovation-led ecosystem with some of the finest start-ups and academia, and drawing from the millennial workforce to create cutting-edge technology solutions and services for its customers.

About i2Chain, Inc.

i2Chain, Inc., is a San Francisco-based cyber security company focused on securing Information and Identity. The firm has a world class team, a combination of experienced former technology executives for Fortune 100 companies with recent computer science graduates, specializing in blockchain and cybersecurity and sharing a passion for developing innovative solutions for clients.

Connect with i2Chain on

Our Social Medial Channels:

For more information on i2Chain, please contact:

Craig Grills, Cofounder & VP Marketing & Alliances

About Tech Mahindra

Tech Mahindra represents the connected world, offering innovative and customer-centric information technology experiences, enabling Enterprises, Associates and the Society to Rise™. We are a USD 4.9 billion company with 121,840+ professionals across 90 countries, helping over 935 global customers including Fortune 500 companies. Our convergent, digital, design experiences, innovation platforms and reusable assets connect across a number of technologies to deliver tangible business value and experiences to our stakeholders. Tech Mahindra is the highest ranked Non-U.S. company in the Forbes Global Digital 100 list (2018) and in the Forbes Fab 50 companies in Asia (2018).

We are part of the USD 21 billion Mahindra Group that employs more than 200,000 people in over 100 countries. The Group operates in the key industries that drive economic growth, enjoying a leadership position in tractors, utility vehicles, after-market, information technology and vacation ownership.

Connect with us on

Our Social Media Channels:

For more information on Tech Mahindra, please contact:

Tuhina Pandey, Global Corporate Communications

Craig Grills
i2Chain, Inc.
+1 813-220-3963
email us here
Visit us on social media:

Source: EIN Presswire

Spartan Micro Appoints Dr. William J. Mack to its Medical Advisory Board

Spartan Micro Logo

Spartan Micro, a neuro and peripheral vascular device company, appointed William J. Mack, MD, MS, FAANS, FAHA, to its Medical Advisory Board.

FREMONT, CA, USA, April 17, 2019 / — Spartan Micro, Inc.,,a neuro and peripheral vascular device company, announced the appointment of William J. Mack, MD, MS, FAANS, FAHA, to its Medical Advisory Board.

As part of our medical advisory board, Dr. Mack will provide knowledge, insight and advice regarding the following:
• Testing and feedback analysis of prototype and late stage proprietary technologies;
• Prioritizing and implementing product development and initiatives;
• Clinical activities; and,
• Long-range strategy for achieving its mission to create safer more effective neurovascular products.

“I am looking forward to working with Spartan Micro, an innovative company with cutting-edge products that can improve and transform the neuroendovascular space.” said Dr. Mack.

“We are extremely pleased at the addition of Dr. Mack to the Spartan Micro team,” said Eric Stoppenhagen, Chief Executive Officer of Spartan Micro. “His vast experience with stroke, brain aneurysms, and intracranial stenosis will give Spartan Micro the ability to develop next generation products.”

About William J. Mack, M.D.
Dr. Mack is a faculty member of the Neuroscience Graduate Program and is the Principal Investigator and Director of the Cerebrovascular Laboratory in the Zilkha Neurogenetic Institute. He receives NIH R01 funding for his laboratory research. Dr. Mack’s scientific interests are focused on translational efforts to treat ischemic and hemorrhagic stroke. Laboratory investigations concentrate on the pathophysiology of cerebral ischemia and inflammatory modulation. Using the information and experience gained in the laboratory, Dr. Mack is working to develop new technologies, techniques, and therapies to directly improve the clinical care administered to stroke patients.

William Mack, MD, received his Bachelor degree with honors from Cornell University. He then attended Columbia University, College of Physicians and Surgeons, where he graduated from medical school (Alpha Omega Alpha) and completed Neurosurgical residency training. During residency, he spent one year performing a post-doctoral cerebrovascular research fellowship under Drs. David J. Pinsky and E. Sander Connolly Jr. at Columbia University. Following residency, Dr. Mack completed an Interventional Neuroradiology/ Neuroendovascular Surgery fellowship at UCLA.

Dr. Mack is board certified by the American Board of Neurological Surgery (FAANS) and is a fellow of the American Heart Association (FAHA) and. He is a committee member on the executive council of the Congress of Neurological Surgeons/ American Association of Neurological Surgeons’ Cerebrovascular Section. Dr. Mack serves as an Associate Editor of the Journal of Neurointerventional Surgery and on the editorial board of World Neurosurgery.

About Spartan Micro, Inc.
Spartan Micro is a neuro and peripheral vascular medical device company based out of Fremont, California, USA. Its focus is research and development, production and sale of medical devices that will include coil embolics, over-the-wire, flow-guided microcatheters, guiding catheters, neurovascular stents and flow diversion stents.
Spartan Micro offers mechanically detachable embolic coils for the occlusion of cerebral aneurysms. In addition to treating cerebral aneurysms, its coils are used in peripheral vascular anatomy for occlusion or flow diversion for other vascular deformities.

Forward-looking Statements
This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) product malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (ix) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (x) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (xi) our reliance on single suppliers for certain product components, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xiii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction.

Eric Stoppenhagen
Spartan Micro, Inc.
+1 512-270-8501
email us here
Visit us on social media:

Source: EIN Presswire




Africa's health challenges require concerted private sector effort to complement governments across the continent.

The time is ripe for the private sector to proactively demonstrate its value in partnering to lead a new era in development.”

— Aliko Dangote, President/CEO, Dangote Group.

LAGOS, LAGOS, NIGERIA, April 17, 2019 / — Fix Health, Fix Africa

The recent commemoration of World Health Day offered Africa a chance to take stock of her health challenges and opportunities. While Africa has made substantial progress in the health space over the past century, she still lags behind the rest of the world in the quality of healthcare and ease of access. Africa accounts for 26% of the global disease burden, while out of pocket expenditure stands at 36% of the continent’s total healthcare spend. The World Health Organization (WHO) predicts that over the next decade, 28 million more lives will be lost to non-communicable diseases in Africa. The fight against Ebola in central Africa is still on while the devastation Cyclone Idai brought to southern Africa has affected almost 3 million people in the region with some 17000 homes destroyed.

Africa’s Economic Landscape
But it is not all bad news. World Bank figures put sub-Saharan Africa’s economic growth at 3.6% in 2019. Africa reportedly has over 400 companies with annual revenue topping a billion dollars and a thriving SME industry that accounts for some 80% of the continent’s employment. By 2040, the continent is expected to have a working population of over one billion people while consumer spending will already exceed $1.4 trillion dollars by the year 2020. These statistics point to a vibrant continental economy with huge potentials to transform the health narratives of the continent. The WHO posits that spending around $30 more per person on the continent to improve well-being should generate $100 billion in economic gains over five years. Evidently, government funding alone cannot make this happen, there is need for concerted efforts from both the public and private sectors with a view to advancing healthier outcomes for the continent.

The ABCHealth Initiative: Rewriting the African Narrative in health
There is an urgent need for Africa to step up action towards ameliorating the perennial health challenges by tapping into its huge human capital, industry and demonstrated private sector successes. Africa’s healthcare systems demand significant investments to meet the needs of its growing population, changing patterns of diseases, and internationally-agreed sustainability development goals. ABCHealth, an African initiative for Africa by Africans championed by Aliko Dangote, is leading the charge to mobilize private sector resources, expertise and innovation to strengthen health systems, save lives across the continent and aid the economic growth and development of Africa. “The time is ripe for the private sector to proactively demonstrate its value in partnering to lead a new era in development,” said Aliko Dangote, President/CEO, Dangote Group.

Private sector investment in the health space has not been insignificant to date, but there is plenty of room for more. Aliko Dangote Foundation’s $100mn funding for nutrition, Patrick Motsepe’s R3.5bn commitment to eradicate poverty through the Global Citizens initiative, as well as other private sector initiatives are already making considerable impact on the continent. Scaling up these investments via collaborations and strategic partnerships will, no doubt, fast-track Africa’s economic growth across all indices.

Investing in key health areas enables businesses, regardless of industry, to improve their bottom line. The World Bank estimates that the Ebola outbreak in West Africa in 2015 cost the region some $2.2m in lost GDP. “What is needed now is an approach that combines the value of local insights and trusted networks with the leverage of a global platform and expertise to support the more coordinated and impactful involvement of the African private sector across the continent and within the global development community,” said Aigboje Aig-Imoukhuede, co-chair, ABCHealth.

The call for action
ABCHealth calls for increased private sector investment in the African health space through strategic partnerships and collaborations towards transforming health outcomes on the continent. Collaborations and partnerships among private sector players, philanthropists and other stakeholders will geometrically increase the impact of health investments across board. Therefore, private sector champions are encouraged to identify possible collaborations for specific projects in order to expand the scope and outcomes of such interventions on the continent.
“Africa’s Private sector needs to also take employee wellness above the regular health insurance plans, where they exist. Routine health awareness, especially around non-communicable diseases, would considerably increase employee output and overall bottom line while retaining the best hands at all times,” said Mercy Machiya, Acting CEO, ABCHealth. It is said that companies with solid employee wellness programmes are consistently rated high amongst the best places to work.

ABCHealth recognizes that this is a critical time for Africa. The continent’s working population is expected to exceed a billion by 2040 while consumer spending will top $1.4trn by 2020. Certainly, a healthier Africa is a prosperous Africa. We cannot drop the ball now; fixing health in Africa is a task that requires both public and private sector involvement because health investments are not just a social imperative but also an economic decision.

On its part, ABCHealth will continue to foster private sector collaborations via strategic partnerships, curate leadership events that will encourage dialogue amongst stakeholders with a view to ensuring Africa not just arrests her festering health challenges but also fulfills potential as one the future economic hotbeds of the world.

For more information on the activities of ABCHealth and membership enquiries, visit or email

Bankole Banjo
+234 703 394 0454
email us here

Source: EIN Presswire

Technology Leverages the Human Voice to Save Lives


Mobile dashboard

ATLANTA, GA, UNITED STATES, April 17, 2019 / — This week, Behavioral Health Link (BHL) together with the Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD) announced a partnership with the US affiliate of Yokohama, Japan-based PST Inc. BHL is collaborating with PST Inc. to leverage the parameters of the human voice to support the professionally-trained BHL call center staff in understanding intensity of distress, an approach that may prove far superior to relying on the specific words and language spoken alone.

In collaboration with research partners in the lab of Dr. Thomas Joiner at Florida State University, responsible for analyzing the outcomes of applying this technology, it is our hope that this Japanese-based technology will add to our clinical toolbox and improve outcomes in the operation of a statewide crisis and access line. For example, the immediate feedback of real-time monitoring of emotional distress would allow call center agents to understand better if they are successfully engaging and calming a person in pain.

We’ll know better as we evaluate the application using the ground-breaking models first used in crisis call centers by Dr. Madelyn Gould and her team at Columbia University more than a decade ago.

Gould and colleagues silently monitored crisis calls and measured the distress of callers using a modification of the Profile of Mood States (POMS). They recorded data at the beginning of crisis calls, again at the conclusion and with consent followed up two weeks later, after an outpatient appointment or other service connection was likely to have been completed. Their research shattered myths about crisis call centers that existed at the time. In fact, callers in very significant distress were utilizing crisis call lines, and the most significant reductions in anguish occurred during the crisis call itself.

We’ll go one step further. This technology will make it easy to look not only at the distress of the individual in crisis but also at ensuring the right level of support for those call center professionals caring for them. Crisis services are very rewarding but challenging work, and we aim to improve the science behind the interventions and the measurement of outcomes in our partnership with PST, Inc.

About PST Inc. (PST: Yokohama, Japan) / PST Health Partners, Inc. (PSTHP: LA, USA)
PST Inc. (PST: Yokohama, Japan) / PST Health Partners, Inc. (PSTHP: LA, USA) has worked in partnership with the University of Tokyo to develop cutting-edge voice analysis technology currently utilized in Japan to detect emotional distress.

About Behavioral Health Link (d/b/a for Integrated Health Resources, Inc.)
“A Crisis Has No Schedule,” and that is why the caring professionals of BHL are available 24/7 to help individuals and communities in crisis. Bolstered by cutting-edge technology developed in house by our dedicated team, BHL has been featured in Crisis Now and has been a national leader in promoting access to and delivery of high-quality crisis care when and where individuals need it most.

About Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD)
Georgia DBHDD provides treatment and support services to people with mental health challenges, substance use disorders, and individuals who live with intellectual and developmental disabilities. The vision is easy access to high-quality care that leads to a life of recovery and independence for the people we serve.

About the FSU Thomas Joiner Lab
The Laboratory for the Study and Prevention of Suicide-Related Conditions and Behaviors at Florida State University focuses primarily on the study of the nature, causes, and management of suicidal behavior and related disorders (e.g., eating disorders, mood disorders, personality disorders). The goal of its research is to refine further and test empirically the interpersonal theory of suicide, as well as understand and prevent suicidal behavior in military and other settings.

About The University of Tokyo, Dr. Shinichi Tokuno Lab
The laboratory for the study of Voice Analysis of Pathophysiology at Graduate school of Medicine, The University of Tokyo focuses primarily on the study of diagnosis and monitoring the mental health condition (e.g. Major Depression Disease). The goal of the research is to verify the technology of mental health condition by voice from voice emotion technology from PST Inc.

Wendy Farmer
+1 706-799-0181
email us here

Source: EIN Presswire

Specialty Pharmaceutical in US Market 2019 Global Forecast, by Players, Types and Forecast To 2024

Specialty Pharmaceutical -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024

PUNE, MAHARASHTRA, INDIA, April 17, 2019 / — Specialty Pharmaceutical Industry


Wiseguyreports.Com Adds “Specialty Pharmaceutical -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database

The US pharmaceutical market is segregated into two types of drugs majorly i.e. traditional drugs and specialty drugs. Specialty drugs in recent times have gained a strong foothold in the US and are likely to experience robust growth in the coming years, with majority of the pharmaceutical companies heading their research and development initiatives towards these drugs.

Specialty drugs are basically meant for chronic and rare disease. Drugs in this category are very expensive and difficult to administer. Also, these drugs require proper management and special handling making them costly. Since, a large part of population in the US is ageing into diseases like cancer, and other deadly diseases, the demand for specialty drugs has skyrocketed in recent times.

The US specialty pharmaceutical market has changed over the span of five years with a lot of these drugs being in their final phase of development. The US specialty pharmaceutical market is likely to grow at staggering growth rate in the coming years majorly due to factors like ageing population of the US, improving life expectancy, rise in real net per capita medicine spending on specialty drugs, and high prevalence of chronic disease in the region.

The market is also undergoing some notable changes that have been covered in the report. The market growth is likely to be hindered by abandonment rate of specialty medicines and high R&D costs. The report offers an in-depth analysis of the “The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)”. Major pharmaceutical companies that have been covered in the report include Celgene Corporation, Gilead Sciences Inc., Amgen Inc., and AbbVie Inc.

Request for Sample Report @

Table of Content

1. Market Overview

    1.1 Introduction 
    1.2 Specialty Pharmaceuticals Vs Traditional Drugs 
    1.3 Application of Specialty Pharmaceuticals 
    1.4 Specialty Pharmacy Services 
    1.5 Specialty Product Distribution 
    1.6 Specialty Pharma Manufacturer Services 
    1.7 Value Proposition of Specialty Pharmacy

2. The US Pharmaceutical Market Analysis

    2.1 The US Pharmaceutical Market by Value 
    2.2 The US Pharmaceutical Market Forecast by Value 
    2.3 The US Pharmaceutical Market by Segment 
      2.3.1 The US Pharmaceutical Market by Segment 
      2.3.2 The US Pharmaceutical Market by Segment Forecast 
      2.3.3 The US Traditional Pharmaceutical Market by Value 
      2.3.4 The US Traditional Pharmaceutical Market Forecast by Value 
    2.4 The US Pharmaceutical Market’s Demand Growth 
    2.5 The US Pharmaceutical Market’s Drug Approval by Segment 
    2.6 The US Pharmaceutical Market by Drugs

3. The US Specialty Pharmaceutical Market

    3.1 The US Specialty Pharmaceutical Market by Value 
    3.2 The US Specialty Pharmaceutical Market Forecast by Value 
    3.3 The US Specialty Pharmaceutical Market by Drugs 
    3.4 The US Specialty Pharmaceutical- Prescription Volume 
      3.4.1 The US Specialty Medication Prescription Volume 
      3.4.2 The US Specialty Medication Prescription Volume Forecast 
      3.4.3 The US Specialty Medication Prescription Volume by Therapeutic Class 
      3.4.4 The US Specialty Medication Prescription Volume Forecast by Therapeutic Class

Leave a Query @

4. Market Dynamics

    4.1 Growth Drivers 
      4.1.1 Rise in Ageing Population of the US 
      4.1.2 Improving Life Expectancy 
      4.1.3 Surge in Spending on Medicines 
      4.1.4 Escalating Per Capita Heath Expenditure in the US 
      4.1.5 Prevalence of Chronic Disease in the US

    4.2 Trend and Opportunities 
      4.2.1 Technology Enabled Transformation 
      4.2.2 Growing Foothold of Oncology Segment 
      4.2.3 Specialty Pharmacy Mergers and Acquisitions

    4.3 Challenges and Issues 
      4.3.1 High Cost of Drugs 
      4.3.2 Abandonment Rates for Branded Medicines 
      4.3.3 High R&D Costs

5. Competitive Landscape

    5.1 The US Specialty Pharmaceutical Market 
      5.1.1 Revenue Comparison by Major Players 
    5.2 The US Specialty Pharmaceutical Market by Therapeutic Class 
      5.2.1 The US Specialty Inflammatory Conditions Market Share by Drugs 
      5.2.2 The US Specialty Oncology Market Share by Drugs 
      5.2.3 The US Specialty Multiple Sclerosis Market Share by Drugs 
      5.2.4 The US Specialty HIV Market Share by Drugs 
      5.2.5 The US Specialty Hepatitis C Market Share by Drugs 
    5.3 The US Specialty Drug Pharmacies Market Share 
    5.4 The US Specialty Product Distribution Market Share

6. Company Profiles

    6.1 Gilead Sciences Inc. 
      6.1.1 Business Overview 
      6.1.2 Financial Overview 
      6.1.3 Business Strategies

    6.2 AbbVie Inc. 
      6.2.1 Business Overview 
      6.2.2 Financial Overview 
      6.2.3 Business Strategies

    6.3 Amgen Inc. 
      6.3.1 Business Overview 
      6.3.2 Financial Overview 
      6.3.3 Business Strategies

    6.4 Celgene Corporation 
      6.4.1 Business Overview 
      6.4.2 Financial Overview 
      6.4.3 Business Strategies

List of Charts

Flow of Products within the Specialty Pharmacy Channel 
SP Benefits Model 
The US Pharmaceutical Market by Value (2012-2016) 
The US Pharmaceutical Market Forecast by Value (2017-2021) 
The US Pharmaceutical Market by Segment (2016) 
The US Pharmaceutical Market by Segment Forecast (2021) 
The US Traditional Pharmaceutical Market by Value (2012-2016) 
The US Traditional Pharmaceutical Market Forecast by Value (2017-2021) 

Buy Now @



Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}

Source: EIN Presswire